Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20200818048445N1Phase 3Completed
Phase 3, open-label trial of propofol, ketamine and fentanyl in anxiety disorder (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Pain. Started Apr 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20200818048445N1.